Researchers said the hybrid virus could help scientists evaluate a range of antibody-based preventives and treatments for COVID-19.
from WebMD Healthhttps://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/other/covid_19_testing_three_other/1800x1200_covid_19_testing_three_other.jpg https://ift.tt/2Ddb7CU
via
IFTTT
Related Posts:
Is Ablation Rx the Best First Choice for A-Fib?
A-fib patients who underwent ablation were half as likely to have an arrhythmia episode in the following year compared to patients on medication. And they were 61% less likely to have an episode that caused symptoms.
from … Read More- What the Pandemic Did to Workouts
By June, just over 60% of those surveyed said they were meeting World Health Organization's guidelines for weekly exercise, representing a nearly 8% jump from pre-pandemic routines. Investigators also found a more than 11% j… Read More
- CDC Urges Americans to Forgo Thanksgiving Travel
With cases already climbing at alarming rates, CDC officials said they were concerned that the holidays may further drive up cases and deaths, particularly for older family members.
from WebMD Healthhttps://img.webmd.com/d… Read More
- 'Unrelenting' COVID Pushes U.S. Deaths Past 250,000
During the last 4 weeks, the number of deaths has jumped by 42%, according to an NBC News analysis. In early October, the weekly average was about 821 deaths per day, which increased to 1,167 deaths per day last week.
from… Read More
- U.S. Leads Wealthy Nations in Pregnancy-Related Deaths
In 2018, the U.S. maternal mortality rate stood at 17 for every 100,000 births -- more than double the rate of most other countries. Those figures capture deaths during pregnancy and within 42 days of the end of pregnancy.
… Read More
0 comments:
Post a Comment